tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Advertisement

Phathom Pharmaceuticals (PHAT) Ownership - Who Owns Phathom Pharmaceuticals?

Compare
523 Followers

Phathom Pharmaceuticals (PHAT) Ownership Overview

11.06%12.78%52.53%7.91%15.72%
11.06% Insiders
52.53% Other Institutional Investors
7.91% ETFs
15.72% Public Companies and
Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 73.22% of the company’s stock is owned by Institutional Investors, 11.06% is owned by Insiders, and 15.72% is owned by Public Companies and Individual Investors.
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 65.30% of the company’s stock is owned by Institutional Investors, 11.06% is owned by Insiders, and 7.91% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 18, 2025
xxxxxxxxxxxxx
$14145
May 23, 2025
xxxxxxxxxxxxx
$14591
May 15, 2025
xxxxxxxxxxxxx
$24455
May 13, 2025
xxxxxxxxxxxxx
$152686

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$300723
Jun 30, 2025
xxxxxxxxxxxxx
$1796120
Jun 30, 2025
xxxxxxxxxxxxx
$5754000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,933,327Insider8.36%60,757,268
2,413,668Institution3.40%24,715,960
2,310,136Institution3.26%23,655,793
1,856,783Institution2.62%19,013,458
1,579,095Institution2.23%16,169,933
1,469,354Institution2.07%15,046,185
1,101,868Insider1.55%11,283,128
746,710Institution1.05%7,646,310
600,000Institution0.85%6,144,000
581,511Institution0.82%5,954,673

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,310,136Institution3.26%23,655,793
1,579,095Institution2.23%16,169,933
1,469,354Institution2.07%15,046,185
746,710Institution1.05%7,646,310
469,987Institution0.66%4,812,667
464,839Institution0.66%4,759,951
456,932Institution0.64%4,678,984
253,000Institution0.36%2,590,720
232,274Institution0.33%2,378,486
221,065Institution0.31%2,263,706

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,554,088Institution2.19%13,271,912
996,086Institution1.40%10,199,921
496,316Institution0.70%4,238,539
321,935Institution0.45%3,296,614
288,736Institution0.41%2,956,657
286,572Institution0.40%2,934,497
269,771Institution0.38%2,824,502
231,276Institution0.33%2,368,266
210,597Institution0.30%2,204,951
201,523Institution0.28%1,721,006

FAQ

Who Owns Phathom Pharmaceuticals (PHAT)?
According to the latest TipRanks data, approximately 52.53% of the company's stock is held by institutional investors, 11.06% is held by insiders, and 15.72% is held by retail investors.
    What percentage of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 52.53% of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors.
      What percentage of Phathom Pharmaceuticals (PHAT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 15.72% of Phathom Pharmaceuticals (PHAT) stock is held by retail investors.
        Who owns the most shares of Phathom Pharmaceuticals (PHAT)?
        James Topper owns the most shares of Phathom Pharmaceuticals (PHAT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis